BCL2 and acute leukemia: In fact, since the dependence on a BCL-2 protein is frequently related to its specific level, tumors with an elevated content of a specific BCL-2 family member can be treated in monotherapy with some BH3-mimetics, such as chronic and acute leukemia with ABT-199.